ARR Autopsy

Every episode tears apart one B2B SaaS company's path from scattered revenue to $1M+ ARR, with the founder who built it sitting across from us. Two hosts grill each guest on the specific acquisition channels, conversion numbers, and operational changes that turned unpredictable income into a system. You'll hear which experiments burned money, which pricing moves doubled close rates, and what the dashboard looked like the month things finally clicked. Built for SaaS founders and growth operators between $200K and $5M ARR who are done with vague strategy talk and want the spreadsheet version of someone else's breakthrough. New episodes drop every Wednesday, brought to you by the team at SaaSLaunch.net.

ARR Autopsy is a general podcast hosted by Unknown Host, with 18 episodes on record and a Required Pod Score of 80.

Unknown Host hosts ARR Autopsy, a general show with 18 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  Episode #23

  Cited, Not Clicked: Testing the 3x-27x AI Claim

  Sep 30, 202619 minS1

  This Wednesday episode, Week 40 of 2026, has no guest and no company ARR to share. Derek and Elena test claims that AI-referred visitors convert anywhere from 3x to 27x better than Google traffic. Their takeaway for B2B SaaS teams: treat every multiplier as an unverified claim until your own funnel data supports it. Topics covered: - Where the multipliers come from, including a vendor roundup citing a 312-firm study and a 23x own-site signup figure that measure different things - Why attribution leaks, from missing referral data to lost CRM source fields, can hide AI-driven acquisition - How to compare AI-referred and Google organic traffic from signup to SQL to closed-won using raw counts, not percentages - What a vendor-run study of 110 brands suggests about wrong AI pricing answers, and what to log and re-check before funding GEO for growth Hosts: Derek and Elena, ARR Autopsy (no guest this episode).

  ListenShow Notes
• 

  Episode #22

  Cold Email at 3.43%: The AI SDR Math That Works

  Sep 23, 202619 minS1

  This episode of ARR Autopsy dissects the cold email reply-rate collapse — down from 5.1% to 3.43% in a single year — and the biggest takeaway for B2B SaaS founders: outbound isn't dead, but the lazy, high-volume blast approach to it is, and teams still running that playbook are quietly burning acquisition spend. Specific topics covered: - Why SDR and BDR headcount fell 36% while senior reply specialists grew 14% in the same year, not as a downturn but a strategy shift - Why 50-70% of AI SDR rollouts churn within nine weeks due to domain damage and reply-rate collapse - How signal-triggered outreach hits 15-25% reply rates and cuts cost per qualified opportunity by 54%, from $487 to $224 - The three-lever decision matrix — volume tier, personalization level, and trigger type — for what to fund next quarter Hosted by Derek and Elena on ARR Autopsy, this is the Wednesday episode for Week 39 of 2026, built for B2B SaaS founders between $200K and $5M ARR making real decisions about growth and acquisition spend.

  ListenShow Notes
• 

  Episode #20

  AWS Marketplace: How 40% of SaaS Revenue Skips CFOs

  Sep 9, 202621 minS1

  This episode of ARR Autopsy examines a claim that AWS, Azure, and Google Cloud marketplaces hold $900 billion in committed spend that can bypass traditional procurement for B2B SaaS purchases, and why that headline number does not hold up against sourced benchmarks. The single biggest takeaway: cloud marketplace private offers can compress procurement from months to days, but founders should treat the $900B figure as an outlier and plan around more conservative projections. Specific topics covered in this Week 37, 2026 Wednesday episode include: - How committed cloud spend through EDP, MACC, and CUD gets redirected into SaaS purchases without new CFO signoff - Why AWS's own $85B-by-2028 estimate is more credible than the widely cited $900B figure - The exact listing-to-close mechanics for structuring a private offer, including AWS's fee cut and express-offer speed - What post-close questions around renewals, channel conflict, and revenue share remain unanswered for founders chasing marketplace-driven growth and acquisition Hosted by Derek and Elena, ARR Autopsy.

  ListenShow Notes
• 

  Episode #19

  Procurement: The 8 Weeks Before 2027 Budgets Lock

  Sep 2, 202614 minS1

  ARR Autopsy digs into the widening gap in AI spending: 86% of enterprises are increasing their AI budgets this year, but only 45% can quantify the return, with governance now the fastest-growing line item forcing new buyer requirements before contracts get signed. This is the Wednesday episode for Week 36 of 2026, built for B2B SaaS founders scaling ARR through enterprise AI deals. - The Q4 budget calendar showing exactly when exploration spend turns into defense spend, by week - Whether founders can charge extra for audit logs and compliance documentation or must absorb it as a cost of doing business - How the $407 billion AI budget splits by sector, and why point solutions face consolidation pressure - Three renewal-deck fixes for the usage forecasting failures that surface after a deal closes Hosted by Derek and Elena, ARR Autopsy.

  ListenShow Notes
• 

  Episode #18

  The $230K AI Inference Leak: A Hosts-Only Deep Dive

  Aug 26, 202619 minS1

  Intercom Fin’s AI pricing shift shows why a hidden 23% inference leak can quietly erase B2B SaaS ARR gains, and how tightening cost-per-action before scale protects growth and acquisition economics. This Wednesday episode for Week 35 of 2026 breaks down why inference spend behaves differently from normal COGS, how it pressures gross margin even as revenue climbs, and what that means for founders sitting between $200K and $5M ARR. In this episode, Derek and Elena unpack how inference costs stay stubborn at scale and why two-thirds of AI-heavy SaaS companies are already feeling margin compression. They walk through buyer pushback and vendor repricing pressure, how outcome-based models like Fin’s change the relationship between unit cost and unit price, and how to work from true cost-per-action up instead of guessing at AI feature pricing. They close with a concrete repricing checklist so you can adjust before enterprise buyers force caps that stall your growth and acquisition roadmap. Host: Derek and Elena, ARR Autopsy.

  ListenShow Notes

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.